Evidence map›Paper›PMID 36140632›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Development and Validation of Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) as a Simple and Rapid Diagnostic Tool for SARS-CoV-2 Detection.

Ahmad M Aldossary, Essam A Tawfik, Musaad A Altammami, Azzam A Alquait, Rayan Y Booq, Bandar K Sendy, Mohammed S Alarawi, Takashi Gojobori, Asmaa M Altamimi, Taghreed A Alaifan and 2 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmad M AldossaryNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.ORCID 0000-0003-0715-6780
Essam A TawfikNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.ORCID 0000-0003-0716-3251
Musaad A AltammamiNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.
Azzam A AlquaitNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.
Rayan Y BooqNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.ORCID 0000-0001-6006-395X
Bandar K SendyNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.ORCID 0000-0003-2970-1882
Mohammed S AlarawiComputational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
Takashi GojoboriComputational Bioscience Research Center, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
Asmaa M AltamimiPublic Health Laboratory, Public Health Authority, Riyadh 13354, Saudi Arabia.ORCID 0000-0003-0381-757X
Taghreed A AlaifanPublic Health Laboratory, Public Health Authority, Riyadh 13354, Saudi Arabia.
Ahmed M AlbarragPublic Health Laboratory, Public Health Authority, Riyadh 13354, Saudi Arabia.
Essam J AlyamaniNational Center of Biotechnology, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia.

Funding

National Industrial Development and Logistics Program (NIDLP) 20-0103 and 20-0051
6 · The paper itself

Abstract

Since the COVID-19 pandemic outbreak in the world, many countries have searched for quick diagnostic tools to detect the virus. There are many ways to design diagnostic assays; however, each may have its limitations. A quick, sensitive, specific, and simple approach is essential for highly rapidly transmitted infections, such as SARS-CoV-2. This study aimed to develop a rapid and cost-effective diagnostic tool using a one-step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) approach. The results were observed using the naked eye within 30-60 min using turbidity or colorimetric analysis. The sensitivity, specificity, and lowest limit of detection (LoD) for SARS-CoV-2 RNA against the RT-LAMP assay were assessed. This assay was also verified and validated against commercial quantitative RT-PCR used by health authorities in Saudi Arabia. Furthermore, a quick and direct sampling from the saliva, or buccal cavity, was applied after simple modification, using proteinase K and heating at 98 °C for 5 min to avoid routine RNA extraction. This rapid single-tube diagnostic tool detected COVID-19 with an accuracy rate of 95% for both genes (

Indexed as

colorimetric assayCOVID-19N geneORF1a geneReverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP)SARS-CoV-2

Identifiers

PMID36140632
PMCPMC9498013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.